http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006193459-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_948c57b2430d2713f72a0c5992c30918
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085caa4347e84b4627ed84d03cd08ce4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e516a6b606b7c0f12b71902a3d8b5911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b67c96a9143065ebf66c3a110e21b9
publicationDate 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006193459-A
titleOfInvention Oral composition for lowering blood cholesterol
abstract Disclosed is a composition for improving hypercholesterolemia by enhancing the effect of isoflavones on lowering total blood cholesterol. An oral composition for lowering blood cholesterol, comprising difructose anhydride and isoflavone and / or a derivative thereof as active ingredients. [Selected drawing] None
priorityDate 2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05168419-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006022003-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11139973-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09255570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004161619-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005225838-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399303

Total number of triples: 40.